Home » Topics » BioWorld Science

BioWorld Science
RSS

Uncovering the regulatory role of a prognostic microRNA in pancreatic ductal adenocarcinoma

Aug. 22, 2018

Ascentage Pharma opens phase I trial of APG-2575 in hematologic malignancies

Aug. 21, 2018

FDA approves expanded label for Keytruda for first-line treatment of metastatic non-squamous NSCLC

Aug. 21, 2018

Phase II trial of TLC-599 for osteoarthritis pain meets primary and key secondary endpoints

Aug. 21, 2018

Japanese approval for Tagrisso as first-line treatment of EGFR-mutated NSCLC

Aug. 21, 2018

New Rho kinase inhibitors described by Chiesi Farmaceutici

Aug. 21, 2018

Hanmi Science patents oncolytic compounds

Aug. 21, 2018

Vectura completes pediatric studies with VR-647 for asthma

Aug. 21, 2018

Antiangiogenic compounds synthesized at Celgene

Aug. 21, 2018

Adare Pharmaceuticals describes cysteamine prodrugs

Aug. 21, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...